About EndoStim

A first-in-class treatment for gastroesophageal reflux disease (GERD)

A first-in-class treatment for gastroesophageal reflux disease (GERD)

EndoStim is a medical device company developing and commercializing a first-in-class neurostimulation treatment system for drug refractory gastroesophageal reflux disease (GERD). 

The EndoStim System is designed to provide long-term reflux control by restoring normal esophageal function.  The System is also designed to preserve normal anatomy to avoid the typical gastrointestinal side effects of traditional anti-reflux surgery. The EndoStim System has been successfully investigated in multiple independent studies.


Important Notice

The EndoStim system is not approved for sale in the US and is limited by US federal law to investigational use only. In the EU and Latin America, EndoStim is not currently commercially available. Information on this website is intended only to provide general information and not as a definitive basis for diagnosis or treatment. Please consult your doctor about your specific condition, contraindications, and possible complications.